Skip to content

What's New

Here you will find information about cancer care and research, news, articles, patient stories and other materials about our work and services. Our Communications serves media and journalists and please contact our Communications via, viestinta@docrates.com.
Articles | Press releases | 20.04.2023
Diagnostics

Breakthroughs in follow-up cancer diagnostics: Recurring cancer can be detected before it reaches full speed

April 20, 2023 | A liquid biopsy using markers released into the bloodstream by cancer cells can reveal the possible...

Press releases | 13.03.2023
Prostate cancer Treatments

Internal radiotherapy is an effective method of treatment for metastatic prostate cancer

Docrates Cancer Center studied the effectiveness of 177Lu-PSMA treatment with a 4-week treatment interval for patients with metastatic castration-resistant prostate...

News | Press releases | 09.03.2023

The number of insured patients has more than tripled in five years

March 9, 2023 | In 2022, nearly 30% of revenue generated by Docrates Cancer Center’s Finnish patients came from insurance...

08.03.2023

Docrates joins EAU23 – Europe’s biggest urological event 10 – 13 March, 2023 in Milan

8.3.2023 | Docrates Cancer Center participates to EAU23 – the Europe’s biggest urological event, which will be held on 10-13...

Press releases | 03.02.2023
Treatments

More and more people are seeking cancer treatment in Finland

Feb 3, 2023 | World Cancer Day takes place on February 4. Docrates Cancer Center treated international patients from more...

News | 18.01.2023
Health and rehabilition

A new solution-focused well-being service for cancer patients

Jan 18, 2023 | The selection of health and well-being services provided by Docrates Cancer Center is expanding. The solution-focused...

News | 01.01.2023
Career story

40 years of treating cancers affecting women

Johanna Mäenpää, MD, PhD, specialist in gynaecological diseases, obstetrics and gynaecological oncology, Professor of Obstetrics and Gynaecology at the University...